Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Substance Abuse Detection | 3 | 2024 | 301 | 1.600 |
Why?
|
| Cannabis | 2 | 2023 | 436 | 1.050 |
Why?
|
| Point-of-Care Systems | 5 | 2022 | 1204 | 0.740 |
Why?
|
| Cannabinoids | 1 | 2023 | 173 | 0.720 |
Why?
|
| Glucose | 2 | 2022 | 4351 | 0.690 |
Why?
|
| Tandem Mass Spectrometry | 3 | 2024 | 1189 | 0.670 |
Why?
|
| Substance-Related Disorders | 3 | 2024 | 4371 | 0.650 |
Why?
|
| Laboratories, Hospital | 1 | 2020 | 193 | 0.640 |
Why?
|
| Clinical Chemistry Tests | 1 | 2018 | 59 | 0.620 |
Why?
|
| Hallucinogens | 1 | 2021 | 194 | 0.610 |
Why?
|
| Chromatography, Liquid | 3 | 2024 | 987 | 0.560 |
Why?
|
| Hemolysis | 2 | 2016 | 423 | 0.550 |
Why?
|
| Lactic Acid | 3 | 2021 | 1134 | 0.510 |
Why?
|
| Blood Specimen Collection | 1 | 2016 | 238 | 0.490 |
Why?
|
| Clinical Laboratory Information Systems | 1 | 2015 | 108 | 0.480 |
Why?
|
| Blood Chemical Analysis | 1 | 2016 | 437 | 0.480 |
Why?
|
| Anemia, Sickle Cell | 1 | 2023 | 1056 | 0.480 |
Why?
|
| Cobalt | 1 | 2014 | 155 | 0.470 |
Why?
|
| Health Literacy | 1 | 2020 | 440 | 0.470 |
Why?
|
| Disaster Planning | 1 | 2020 | 558 | 0.460 |
Why?
|
| Ambulatory Care Facilities | 1 | 2020 | 926 | 0.460 |
Why?
|
| Communicable Diseases | 1 | 2022 | 878 | 0.460 |
Why?
|
| Hypercalcemia | 1 | 2017 | 421 | 0.460 |
Why?
|
| Quality Control | 1 | 2016 | 828 | 0.440 |
Why?
|
| Outpatients | 1 | 2021 | 1607 | 0.430 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2013 | 127 | 0.430 |
Why?
|
| Acute Kidney Injury | 2 | 2021 | 1941 | 0.400 |
Why?
|
| Laboratories | 4 | 2024 | 462 | 0.400 |
Why?
|
| Erythrocytes | 2 | 2013 | 2415 | 0.400 |
Why?
|
| Specimen Handling | 1 | 2016 | 707 | 0.380 |
Why?
|
| Oxygen | 1 | 2023 | 4193 | 0.380 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2017 | 749 | 0.380 |
Why?
|
| Income | 1 | 2020 | 1875 | 0.370 |
Why?
|
| Blood Glucose | 2 | 2022 | 6381 | 0.360 |
Why?
|
| Emergency Service, Hospital | 4 | 2024 | 7818 | 0.360 |
Why?
|
| Legislation, Drug | 2 | 2023 | 214 | 0.350 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2016 | 833 | 0.330 |
Why?
|
| Hepatitis C, Chronic | 1 | 2017 | 1031 | 0.330 |
Why?
|
| Luminescence | 1 | 2009 | 133 | 0.320 |
Why?
|
| Hip Prosthesis | 1 | 2014 | 920 | 0.310 |
Why?
|
| Antibodies, Viral | 4 | 2023 | 3143 | 0.300 |
Why?
|
| Reference Standards | 2 | 2022 | 1004 | 0.260 |
Why?
|
| Vitamin D | 2 | 2020 | 3291 | 0.250 |
Why?
|
| Immunoassay | 4 | 2024 | 746 | 0.230 |
Why?
|
| Humans | 39 | 2024 | 760621 | 0.230 |
Why?
|
| Computational Biology | 1 | 2015 | 3505 | 0.220 |
Why?
|
| Colorado | 1 | 2023 | 164 | 0.210 |
Why?
|
| Vaccines, Synthetic | 2 | 2022 | 617 | 0.210 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2009 | 806 | 0.210 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3085 | 0.210 |
Why?
|
| Sensitivity and Specificity | 6 | 2023 | 14660 | 0.200 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3205 | 0.200 |
Why?
|
| Oxyhemoglobins | 1 | 2023 | 212 | 0.200 |
Why?
|
| Antibodies, Neutralizing | 2 | 2022 | 1933 | 0.200 |
Why?
|
| Physicians | 1 | 2020 | 4591 | 0.200 |
Why?
|
| Fentanyl | 1 | 2024 | 434 | 0.190 |
Why?
|
| 25-Hydroxyvitamin D 2 | 1 | 2020 | 40 | 0.180 |
Why?
|
| Immunoglobulin M | 2 | 2023 | 1529 | 0.180 |
Why?
|
| Automation, Laboratory | 1 | 2021 | 103 | 0.180 |
Why?
|
| Oximetry | 1 | 2023 | 461 | 0.170 |
Why?
|
| Metabolomics | 1 | 2009 | 1628 | 0.170 |
Why?
|
| Acidosis | 1 | 2021 | 268 | 0.170 |
Why?
|
| Immunoglobulin A | 1 | 2023 | 979 | 0.170 |
Why?
|
| Pandemics | 4 | 2024 | 8624 | 0.160 |
Why?
|
| Bicycling | 1 | 2020 | 176 | 0.160 |
Why?
|
| Creatinine | 2 | 2021 | 1903 | 0.160 |
Why?
|
| Health Planning | 1 | 2020 | 232 | 0.160 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2022 | 457 | 0.160 |
Why?
|
| Reproducibility of Results | 5 | 2024 | 20080 | 0.160 |
Why?
|
| Immune Evasion | 1 | 2022 | 362 | 0.150 |
Why?
|
| Ethanol | 1 | 2024 | 1323 | 0.150 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2020 | 258 | 0.150 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2021 | 592 | 0.130 |
Why?
|
| Calcitonin | 1 | 2017 | 330 | 0.130 |
Why?
|
| United States | 5 | 2023 | 72461 | 0.130 |
Why?
|
| Automobile Driving | 1 | 2020 | 438 | 0.120 |
Why?
|
| Analgesics | 1 | 2021 | 1065 | 0.120 |
Why?
|
| Accidents, Traffic | 1 | 2020 | 814 | 0.120 |
Why?
|
| Biological Assay | 1 | 2017 | 630 | 0.120 |
Why?
|
| Erythrocyte Count | 1 | 2014 | 157 | 0.120 |
Why?
|
| Canada | 1 | 2020 | 2128 | 0.120 |
Why?
|
| Boston | 2 | 2024 | 9280 | 0.110 |
Why?
|
| Immunoglobulin G | 2 | 2023 | 4541 | 0.110 |
Why?
|
| Leukocyte Count | 1 | 2017 | 1600 | 0.110 |
Why?
|
| Walking | 1 | 2020 | 1189 | 0.110 |
Why?
|
| CA-19-9 Antigen | 1 | 2013 | 106 | 0.110 |
Why?
|
| Sepsis | 2 | 2017 | 2592 | 0.100 |
Why?
|
| Platelet Function Tests | 1 | 2014 | 303 | 0.100 |
Why?
|
| alpha-Fetoproteins | 1 | 2013 | 222 | 0.100 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2013 | 336 | 0.100 |
Why?
|
| Immobilized Proteins | 1 | 2011 | 25 | 0.100 |
Why?
|
| Leukocyte Rolling | 1 | 2011 | 69 | 0.090 |
Why?
|
| Platelet Aggregation | 1 | 2014 | 805 | 0.090 |
Why?
|
| Ascites | 1 | 2013 | 338 | 0.090 |
Why?
|
| Acetabulum | 1 | 2014 | 541 | 0.090 |
Why?
|
| Data Mining | 1 | 2015 | 553 | 0.090 |
Why?
|
| Hepacivirus | 1 | 2017 | 1334 | 0.090 |
Why?
|
| Linear Models | 2 | 2018 | 5877 | 0.090 |
Why?
|
| Pelvis | 1 | 2014 | 743 | 0.090 |
Why?
|
| United States Food and Drug Administration | 1 | 2018 | 1677 | 0.090 |
Why?
|
| Polycarboxylate Cement | 1 | 2009 | 18 | 0.080 |
Why?
|
| Antibodies | 1 | 2017 | 2421 | 0.080 |
Why?
|
| Adult | 5 | 2024 | 219994 | 0.080 |
Why?
|
| RNA, Viral | 1 | 2017 | 2838 | 0.080 |
Why?
|
| Ticlopidine | 1 | 2014 | 895 | 0.080 |
Why?
|
| P-Selectin | 1 | 2011 | 599 | 0.080 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2009 | 142 | 0.080 |
Why?
|
| Isoenzymes | 1 | 2013 | 1690 | 0.080 |
Why?
|
| Self Report | 1 | 2020 | 3711 | 0.080 |
Why?
|
| Hospitals | 1 | 2022 | 3928 | 0.080 |
Why?
|
| Porosity | 1 | 2009 | 349 | 0.080 |
Why?
|
| NADP | 1 | 2009 | 223 | 0.080 |
Why?
|
| Terminology as Topic | 1 | 2015 | 1535 | 0.080 |
Why?
|
| Female | 9 | 2024 | 391270 | 0.070 |
Why?
|
| Membranes, Artificial | 1 | 2009 | 367 | 0.070 |
Why?
|
| Patient Satisfaction | 1 | 2020 | 3448 | 0.070 |
Why?
|
| Hemoglobins | 1 | 2013 | 1521 | 0.070 |
Why?
|
| Fluorescence | 1 | 2009 | 751 | 0.070 |
Why?
|
| Glutathione | 1 | 2009 | 582 | 0.070 |
Why?
|
| Calibration | 1 | 2009 | 816 | 0.070 |
Why?
|
| Sex Factors | 1 | 2020 | 10547 | 0.070 |
Why?
|
| Aged | 4 | 2021 | 169152 | 0.060 |
Why?
|
| Male | 8 | 2024 | 359744 | 0.060 |
Why?
|
| Healthcare Disparities | 1 | 2020 | 3388 | 0.060 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2022 | 5649 | 0.060 |
Why?
|
| Calcium | 1 | 2017 | 5725 | 0.060 |
Why?
|
| Cell Death | 1 | 2009 | 1672 | 0.060 |
Why?
|
| Limit of Detection | 1 | 2024 | 280 | 0.060 |
Why?
|
| Radiography | 1 | 2014 | 6965 | 0.060 |
Why?
|
| Adenosine Triphosphate | 1 | 2009 | 1993 | 0.050 |
Why?
|
| Rabbits | 1 | 2009 | 4773 | 0.050 |
Why?
|
| Middle Aged | 4 | 2024 | 220352 | 0.050 |
Why?
|
| Aspirin | 1 | 2014 | 3364 | 0.050 |
Why?
|
| Mass Screening | 1 | 2017 | 5423 | 0.050 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2014 | 3201 | 0.050 |
Why?
|
| Hospitalization | 1 | 2021 | 10790 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2011 | 3707 | 0.040 |
Why?
|
| Blood Coagulation Tests | 1 | 2021 | 270 | 0.040 |
Why?
|
| Cross Reactions | 1 | 2022 | 818 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2020 | 80372 | 0.040 |
Why?
|
| Cryoelectron Microscopy | 1 | 2022 | 642 | 0.040 |
Why?
|
| Crystallography, X-Ray | 1 | 2022 | 1982 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2021 | 2502 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2021 | 1180 | 0.030 |
Why?
|
| Workflow | 1 | 2021 | 852 | 0.030 |
Why?
|
| Epitopes | 1 | 2022 | 2503 | 0.030 |
Why?
|
| Polysaccharides | 1 | 2022 | 1016 | 0.030 |
Why?
|
| Blood Coagulation | 1 | 2021 | 1157 | 0.030 |
Why?
|
| Fetal Blood | 1 | 2021 | 1343 | 0.030 |
Why?
|
| Trauma Centers | 1 | 2020 | 933 | 0.030 |
Why?
|
| Vaccines | 1 | 2022 | 832 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2022 | 1885 | 0.030 |
Why?
|
| Arachidonic Acid | 1 | 2014 | 433 | 0.030 |
Why?
|
| Ascitic Fluid | 1 | 2013 | 189 | 0.030 |
Why?
|
| Young Adult | 1 | 2018 | 58741 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2022 | 5434 | 0.020 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2011 | 110 | 0.020 |
Why?
|
| Benzophenones | 1 | 2011 | 58 | 0.020 |
Why?
|
| Photochemical Processes | 1 | 2011 | 86 | 0.020 |
Why?
|
| HL-60 Cells | 1 | 2011 | 363 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2013 | 956 | 0.020 |
Why?
|
| Jurkat Cells | 1 | 2011 | 736 | 0.020 |
Why?
|
| Protein Binding | 1 | 2022 | 9335 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2021 | 8555 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2024 | 3763 | 0.020 |
Why?
|
| Time Factors | 1 | 2009 | 40165 | 0.020 |
Why?
|
| Video Recording | 1 | 2011 | 955 | 0.020 |
Why?
|
| ROC Curve | 1 | 2013 | 3568 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2017 | 9716 | 0.020 |
Why?
|
| Neoplasms | 1 | 2013 | 22072 | 0.010 |
Why?
|
| Prevalence | 1 | 2020 | 15687 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2021 | 26181 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 25942 | 0.010 |
Why?
|
| Mutation | 1 | 2022 | 29932 | 0.010 |
Why?
|
| Animals | 1 | 2009 | 167963 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2013 | 22053 | 0.010 |
Why?
|
| Risk Factors | 1 | 2020 | 74359 | 0.010 |
Why?
|
Concepts
(177)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(48)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_